2-Methylimidazole
Names | |
---|---|
Other names
2-MeIm | |
Identifiers | |
693-98-1 | |
3D model (Jmol) | Interactive image |
ChemSpider | 12225 |
ECHA InfoCard | 100.010.697 |
PubChem | 12749 |
| |
| |
Properties | |
C4H6N2 | |
Molar mass | 82.10 g/mol |
Appearance | white or colorless solid |
Melting point | 145 °C (293 °F; 418 K) |
Boiling point | 270 °C (518 °F; 543 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
2-Methylimidazole is an organic compound that is structurally related to imidazole with the chemical formula CH3C3H2N2H. It is a white or colorless solid that is highly soluble in polar organic solvents. It is a precursor to a range of drugs and is a ligand in coordination chemistry.
Synthesis and reactions
It is prepared by condensation of glyoxal, ammonia, and acetaldehyde, a Radziszewski reaction. Nitration gives 5-nitro derivative.[1]
2-Methylimidazole is a sterically hindered imidazole that is used to similuate the coordination of histidine to heme complexes. It can be deprotonated to make imidazolate-based coordination polymers.[2]
Applications
2-Methylimidazole is a precursor to the several members of the nitroimidazole antibiotics that are used to combat anaerobic bacterial and parasitic infections.[3][1]
Safety
It has low toxicity with an LD50 (rat, oral) of 1300 mg/kg, but it is strongly irritating to the skin and eyes.[1]
References
- 1 2 3 Ebel, K., Koehler, H., Gamer, A. O., & Jäckh, R. "Imidazole and Derivatives." In Ullmann’s Encyclopedia of Industrial Chemistry; 2002 Wiley-VCH, doi:10.1002/14356007.a13_661
- ↑ Banerjee, Rahul; Phan, Anh; Wang, Bo; Knobler, Carolyn; Furukawa, Hiroyasu; O'Keeffe, Michael; Yaghi, Omar M (2008). "High-Throughput Synthesis of Zeolitic Imidazolate Frameworks and Application to CO2 Capture". Science. 319: 939–943. doi:10.1126/science.1152516.
- ↑ Edwards, David I (1993). "Nitroimidazole drugs - action and resistance mechanisms. I. Mechanism of action". Journal of Antimicrobial Chemotherapy. 31: 9–20. doi:10.1093/jac/31.1.9.